• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

A Novel Algorithm for Streamlining Diagnosis of Advanced Liver Fibrosis in CHB Patients with Concurrent Hepatic Steatosis.

作者信息

Xu Xiaoming, Rui Fajuan, Ni Wenjing, Wu Chao, Shi Junping, Li Jie

机构信息

Department of Infectious Diseases, Nanjing Drum Tower Hospital Clinical College of Nanjing University of Chinese Medicine, Nanjing, Jiangsu, China.

Department of Infectious Diseases, Nanjing Drum Tower Hospital, Affiliated Hospital of Medical School, Nanjing University, Nanjing, Jiangsu, China.

出版信息

J Clin Transl Hepatol. 2024 Feb 28;12(2):222-226. doi: 10.14218/JCTH.2023.00362. Epub 2024 Jan 29.

DOI:10.14218/JCTH.2023.00362
PMID:38343608
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10851070/
Abstract
摘要
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1dfb/10851070/5b5f95c4a0c5/JCTH-12-222-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1dfb/10851070/5b5f95c4a0c5/JCTH-12-222-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1dfb/10851070/5b5f95c4a0c5/JCTH-12-222-g001.jpg

相似文献

1
A Novel Algorithm for Streamlining Diagnosis of Advanced Liver Fibrosis in CHB Patients with Concurrent Hepatic Steatosis.一种用于简化合并肝脂肪变性的慢性乙型肝炎患者晚期肝纤维化诊断的新算法。
J Clin Transl Hepatol. 2024 Feb 28;12(2):222-226. doi: 10.14218/JCTH.2023.00362. Epub 2024 Jan 29.
2
Fatty liver is associated with advanced fibrosis but does not predict adverse outcomes in patients with chronic hepatitis B.脂肪肝与晚期纤维化相关，但不能预测慢性乙型肝炎患者的不良结局。
J Viral Hepat. 2020 Dec;27(12):1297-1305. doi: 10.1111/jvh.13361. Epub 2020 Aug 27.
3
Hepatic steatosis and fibrosis in young men with treatment-naïve chronic hepatitis B.未经治疗的慢性乙型肝炎青年男性的肝脂肪变性和肝纤维化
Liver Int. 2009 Jul;29(6):878-83. doi: 10.1111/j.1478-3231.2009.01976.x. Epub 2009 Jan 22.
4
Hepatic steatosis in chronic hepatitis B patients is associated with metabolic factors more than viral factors.慢性乙型肝炎患者的肝脂肪变性与代谢因素的关联大于病毒因素。
J Gastroenterol Hepatol. 2008 Jul;23(7 Pt 1):1082-8. doi: 10.1111/j.1440-1746.2008.05478.x.
5
Noninvasive Diagnosis of Hepatic Steatosis Using Fat Attenuation Parameter Measured by FibroTouch and a New Algorithm in CHB Patients.利用FibroTouch测量的脂肪衰减参数及新算法对慢性乙型肝炎患者肝脂肪变性进行无创诊断
Hepat Mon. 2016 Jul 24;16(9):e40263. doi: 10.5812/hepatmon.40263. eCollection 2016 Sep.
6
[Prevalence and risk factors of hepatic steatosis in patients with chronic hepatitis B].[慢性乙型肝炎患者肝脂肪变性的患病率及危险因素]
Zhonghua Gan Zang Bing Za Zhi. 2008 Jul;16(7):519-23.
7
Liver stiffness as measured by two-dimensional shear wave elastography overestimates the stage of fibrosis in patients with chronic hepatitis B and hepatic steatosis.二维剪切波弹性成像测量的肝脏硬度在慢性乙型肝炎和肝脂肪变性患者中高估了纤维化的分期。
Clin Res Hepatol Gastroenterol. 2021 Mar;45(2):101421. doi: 10.1016/j.clinre.2020.03.021. Epub 2020 Apr 17.
8
[Analysis of clinical and pathological features of chronic hepatitis B with hepatic steatosis].[慢性乙型肝炎合并肝脂肪变性的临床及病理特征分析]
Zhonghua Gan Zang Bing Za Zhi. 2009 Nov;17(11):817-20.
9
Moderate to severe hepatic steatosis leads to overestimation of liver stiffness measurement in chronic hepatitis B patients without significant fibrosis.中重度肝脂肪变可导致慢性乙型肝炎无显著纤维化患者肝硬度测量值偏高。
Aliment Pharmacol Ther. 2019 Jul;50(1):93-102. doi: 10.1111/apt.15298. Epub 2019 May 16.
10
The utility of non-invasive tests to assess advanced fibrosis in Asian subjects with chronic hepatitis B and concomitant hepatic steatosis.评估慢性乙型肝炎合并肝脂肪变性亚洲受试者肝纤维化程度的非侵入性检测方法的效用。
Liver Int. 2023 May;43(5):1008-1014. doi: 10.1111/liv.15541. Epub 2023 Mar 20.

本文引用的文献

1
Using the ELF test, FIB-4 and NAFLD fibrosis score to screen the population for liver disease.应用 ELF 试验、FIB-4 和 NAFLD 纤维化评分对人群进行肝病筛查。
J Hepatol. 2023 Aug;79(2):277-286. doi: 10.1016/j.jhep.2023.04.002. Epub 2023 Apr 21.
2
Non-invasive diagnosis and monitoring of non-alcoholic fatty liver disease and non-alcoholic steatohepatitis.非酒精性脂肪性肝病和非酒精性脂肪性肝炎的无创诊断和监测。
Lancet Gastroenterol Hepatol. 2023 Jul;8(7):660-670. doi: 10.1016/S2468-1253(23)00066-3. Epub 2023 Apr 13.
3
Noninvasive assessment of liver disease severity in patients with nonalcoholic fatty liver disease (NAFLD) and type 2 diabetes.
非酒精性脂肪性肝病（NAFLD）合并 2 型糖尿病患者肝纤维化的无创评估。
Hepatology. 2023 Jul 1;78(1):195-211. doi: 10.1097/HEP.0000000000000351. Epub 2023 Mar 17.
4
The utility of non-invasive tests to assess advanced fibrosis in Asian subjects with chronic hepatitis B and concomitant hepatic steatosis.评估慢性乙型肝炎合并肝脂肪变性亚洲受试者肝纤维化程度的非侵入性检测方法的效用。
Liver Int. 2023 May;43(5):1008-1014. doi: 10.1111/liv.15541. Epub 2023 Mar 20.
5
Real-world evidence on non-invasive tests and associated cut-offs used to assess fibrosis in routine clinical practice.关于在常规临床实践中用于评估纤维化的非侵入性检测及相关临界值的真实世界证据。
JHEP Rep. 2022 Sep 22;5(1):100596. doi: 10.1016/j.jhepr.2022.100596. eCollection 2023 Jan.
6
Increased Risk of Liver-Related Outcomes in Chronic Hepatitis B Patients with Metabolic Syndrome: A Systematic Review and Meta-Analysis.代谢综合征对慢性乙型肝炎患者肝脏相关结局的影响：系统评价和荟萃分析。
Dig Dis. 2022;40(6):745-753. doi: 10.1159/000521768. Epub 2022 Jan 5.
7
Low Accuracy of FIB-4 and NAFLD Fibrosis Scores for Screening for Liver Fibrosis in the Population.人群中 FIB-4 和 NAFLD 纤维化评分对筛查肝纤维化的准确性低。
Clin Gastroenterol Hepatol. 2022 Nov;20(11):2567-2576.e6. doi: 10.1016/j.cgh.2021.12.034. Epub 2021 Dec 29.
8
Systematic review with meta-analysis: prevalence of hepatic steatosis, fibrosis and associated factors in chronic hepatitis B.系统评价与荟萃分析：慢性乙型肝炎患者肝脂肪变、肝纤维化及其相关因素的流行情况。
Aliment Pharmacol Ther. 2021 Nov;54(9):1100-1109. doi: 10.1111/apt.16595. Epub 2021 Sep 1.
9
Diagnostic accuracy of non-invasive tests for advanced fibrosis in patients with NAFLD: an individual patient data meta-analysis.非酒精性脂肪性肝病患者肝纤维化无创性检查诊断准确性的个体患者数据分析荟萃研究。
Gut. 2022 May;71(5):1006-1019. doi: 10.1136/gutjnl-2021-324243. Epub 2021 May 17.
10
Prevalence, incidence, and outcome of non-alcoholic fatty liver disease in Asia, 1999-2019: a systematic review and meta-analysis.亚洲地区非酒精性脂肪性肝病的流行率、发病率和结局：系统评价和荟萃分析。
Lancet Gastroenterol Hepatol. 2019 May;4(5):389-398. doi: 10.1016/S2468-1253(19)30039-1. Epub 2019 Mar 20.